Evidence map›Paper›PMID 29325546›Full record

ArticleHealth and quality of life outcomes2018

Development and evaluation of a measure of patient-reported symptoms of Blepharitis.

Kamran Hosseini, Linda B Bourque, Ron D Hays

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01408082 (A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-502 Compared to AzaSite Alone, Dexamethasone Alone, and Vehicle in the Treatment of Subjects With Non-Bacterial Blepharitis), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01408082 phase3completednot on this map

A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-502 Compared to AzaSite Alone, Dexamethasone Alone, and Vehicle in the Treatment of Subjects With Non-Bacterial Blepharitis

TypeinterventionalSponsorSun Pharmaceutical Industries LimitedRan2011 to 2013Enrolled917ConditionsBlepharitisArmsISV-502 (1.0% azithromycin and 0.1% dexamethasone combined), Azasite, Dexamethasone, Vehicle
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Ophthalmologic Comorbidities in Alopecia Areata.Journal of clinical medicine · 2025
    Review
  6. Article
  7. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment ofHealthcare (Basel, Switzerland) · 2024
    Review
  8. Global Trends in Studies on the Presence ofJournal of arthropod-borne diseases · 2024
    Article
  9. Developing and validating a questionnaire to assess the symptoms of blepharitis accompanied by dry eye disease.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  10. Life (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Psychosocial Impact ofClinical ophthalmology (Auckland, N.Z.) · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kamran HosseiniInSite Vision, Clinical and Regulatory Affairs, 965 Atlantic Avenue, Alameda, CA, 94501, USA. Hosseini.kamran@gmail.com.ORCID http://orcid.org/0000-0002-9426-2962
Linda B BourqueUCLA Department of Community Health Sciences, 10833 Le Conte Avenue, 41-230 CHS, Los Angeles, CA, 90095-1772, USA.
Ron D HaysUCLA Department of Medicine, Division of General Internal Medicine & Health Services Research, 911 Broxton Avenue, Los Angeles, CA, 90024, USA.
UCLA Health · USUnited States Nuclear Regulatory Commission · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlepharitis is an ocular surface disease and chronic ophthalmic condition. This paper reports on the development of psychometric evaluation of a patient-reported measure of blepharitis symptoms.

methodsSelf-reports of 13 blepharitis symptoms collected in a Phase 3 multi-site, randomized, double-masked, 4-arm parallel group, clinical trial of 907 individuals with blepharitis (mean age = 62, range: 19-93; 57% female) were analyzed. Symptoms asked about were: eyes that itch; eyes that burn; eyelids feel heavy or puffy; feel like something is in your eye; dry eyes; gritty eyes; irritated eyes; eyes that tear or water; crusty eyes; flaking from your eyelids; eyelids that are stuck together; red eyes or eyelids; and debris like pieces of skin or dandruff in your eyes.

resultsCategorical factor analyses provided support for two multi-item symptom scales: Irritation (9 items, alpha = 0.88) and Debris (4 items, alpha = 0.85). Spearman-rank order correlations of the Irritation and Debris scales with the Ocular Surface Disease total score were 0.63 and 0.41, respectively (p's < 0.001). Rank-order correlations between ratings of clinicians and self-reports of puffy eyes (r = 0.07, p < .05), red eyes (r = 0.12, p < .001), debris (r = 0.03, p > 0.05), and irritation (r = 0.47, p < .001).

conclusionsThis study provides support for the psychometric properties and construct validity of the Irritation and Debris scales for assessing symptoms of blepharitis. The associations between the self-reports and clinician ratings of 4 symptoms indicate substantial unique information in the new self-reported symptom items.

trial registrationThe trial was registered at ClinicalTrials.gov under the registry number NCT01408082 .

Indexed as

Self ReportAdultAgedAged, 80 and overBlepharitisDouble-Blind MethodFemaleHumansMaleMiddle AgedPsychometricsQuality of LifeSymptom AssessmentYoung AdultBlepharitisReliabilitySymptomsValidity

Identifiers

PMID29325546
PMCPMC5765649
OpenAlexW2784293308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.